Search Icon
SideMenu
Home
Press Releases

Press Releases
  • Press Releases

AAM Comments on Section 232 Investigation on Pharmaceuticals
  • Press Releases

AAM Commends Senate Q1/Q2 Bill Introduction
  • Press Releases

AAM Congratulates Dr. Oz on Confirmation as Administrator of the Centers for Medicare & Medicaid Services
  • Press Releases

AAM Comments on staff layoffs at FDA
  • Press Releases

AAM Congratulates FDA Commissioner Makary
  • Press Releases

AAM Commends Q1/Q2 House Bill Reintroduction
  • Press Releases

Association for Accessible Medicines on Confirmation of Robert F. Kennedy Jr. as Secretary of Health and Human Services
  • Press Releases

Association for Accessible Medicines 2025 Advocacy Priorities
  • Press Releases

Association for Accessible Medicines Comments on New Tariffs
  • Press Releases

Keren Haruvi Reelected Chair of the Association for Accessible Medicines Board of Directors
  • Press Releases

AAM Comments on Medicare Drug Price Negotiation List
  • Press Releases

AAM Applauds Senate Bill to Protect Patient Access to Affordable Medicines
Load More
Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington DC 20001
JOIN

Advocacy

About Us

Events

Resources

Sign-up for Update

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Subscribe

© 2025 Association for Accessible Medicines (AAM), All Rights Reserved
Privacy Policy  |  Terms of Use  |  Contact

Stay Connected

For the latest updates, follow us on social media.

Facebook-f X-twitter Linkedin-in Youtube Instagram